PT  - JOURNAL ARTICLE
AU  - Song, H
AU  - Kim, M-J
AU  - Chung, C H
AU  - Choo, S J
AU  - Song, M G
AU  - Song, J-M
AU  - Kang, D-H
AU  - Lee, J W
AU  - Song, J-K
TI  - Factors associated with development of late significant tricuspid regurgitation after successful left-sided valve surgery
AID  - 10.1136/hrt.2008.152793
DP  - 2009 Jun 01
TA  - Heart
PG  - 931--936
VI  - 95
IP  - 11
4099  - http://heart.bmj.com/content/95/11/931.short
4100  - http://heart.bmj.com/content/95/11/931.full
SO  - Heart2009 Jun 01; 95
AB  - Background: Persistent significant tricuspid regurgitation (TR) after successful left-sided valve surgery is frequently reported. Objectives: To evaluate the incidence, risk factors and clinical impact of development of late significant TR after successful left-sided valve surgery. Methods and results: 638 patients (356 men, mean age 52 (SD 14) years) who had mild (⩽grade 2/4) TR and underwent successful surgery without any procedure for TR were analysed. Development of significant TR was defined as a TR increase by more than one grade and final TR grade ⩾3/4 at follow-up echocardiography. Clinical events were defined as cardiovascular death, repeated open-heart surgery, and congestive heart failure requiring hospital admission. The overall incidence of late significant TR was 7.7% (49/638). Age (hazard ratio (HR), 1.0, 95% CI, 1.0 to 1.1; p = 0.005), female gender (HR, 5.0; 95% CI 2.0 to 12.7; p = 0.001), rheumatic aetiology (HR, 3.8; 95% CI 1.4 to 10.3; p = 0.011), atrial fibrillation (Af) (HR, 2.6; 95% CI 1.1 to 6.4; p = 0.035) and peak pressure gradient of TR at follow-up (HR, 1.1; 95% CI 1.0 to 1.1; p<0.001) were independent factors associated with development of late significant TR. During clinical follow-up of 101 (24) months, patients who developed late significant TR showed a significantly lower 8-year clinical event-free survival rate (76 (6) vs 91 (1)%, p<0.001). Conclusions: Several clinical variables were independent risk factors for development of late significant TR. Early surgical intervention for TR in selected patients with these risk factors may be justified, even though they have only mild TR.